Health Care: Drugs

Athersys Inc (ATHX: NASDAQ)

$1.29 n/a | n/a%
10/22/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.29
52 Week High 4.33
52 Week Low 1.08
Avg. Daily Vol. (Mil) 0.30
Beta (3 year) -0.26
Share Related Items
Mkt Cap (Mil) 99.69
Shares Out (Mil) 77.28
Float (Mil) 76.01
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 8.80
Current Ratio 8.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.01
Valuation Ratios
Price Earnings n.a.
Price/Sales 37.82
Price/Book 3.23
Price/Cash Flow -3.90
Per Share Data
Earnings -0.40
Sales 0.03
Book Value 0.40
Cash Flow -0.33
Business Summary
Athersys Inc is a biopharmaceutical company developing regenerative medicine. It is engaged in the discovery and development of therapies designed to extend and enhance human life.
General Information
3201 Carnegie Avenue
Cleveland, OH 44115-2634
www.athersys.com
Industry : Drugs
Sector: Health Care
Employees: 56
CEO: Dr. Gil Van Bokkelen
Short Interest
Current Month (Mil) 2.70
Previous Month (Mil) 2.83
Short Interest Ratio (Days) 10.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -63.80
Return on Investments -84.90
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter